GL1X · GenesisL1 explorer

MolNFT v1 · #147890 · protein

Human SIRT5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29

6EQS · NAD-dependent protein deacylase sirtuin-5, mitochondrial: “Human SIRT5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29”. X-ray diffraction, 2 ligands (BV8, ZN), 11 pockets (best druggability 0.82).…

PDB
6EQS
Type
protein
Length
1,086 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacylase sirtuin-5, mitochondrial
EC
3.5.1.-
UniProt
Q9NXA8
Ligands
BV8, ZN
Pockets
11 · best druggability 0.82

Structure

x-ray diffraction · 4 distinct chains · 38% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-)protein26938% helix, 19% strandQ9NXA8
BNAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-)protein26839% helix, 19% strandQ9NXA8
CNAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-)protein27438% helix, 19% strandQ9NXA8
DNAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-)protein27537% helix, 19% strandQ9NXA8

Ligands and binding sites

  • BV8 · 3-[[(~{Z})-~{C}-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3, 4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]sulfanyl-~{N}-[(5~{S})-6-[[(2~{S})-3-(1~{H}-indol-3-yl)-1-oxidanylidene-1-(propan-2-ylamino)propan-2-yl]amino]-6-oxidanylidene-5-(phenylmethoxycarbonylamino) hexyl]carbonimidoyl]amino]propanoic acid · ligand · 4 copies · chains A, D, B, C
  • ZN · Zinc ion · metal · 4 copies · chains A, B, C, D
  • EDO · 1,2-ethanediol · additive · 15 copies · chains A, B, C, D
  • BU2 · 1,3-butanediol · additive · 8 copies · chains A, B, C, D
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110210.820.83102BV8, EDO
29330.800.8294BV8, EDO, BU2
34600.770.8558BV8, EDO, DMS
44430.770.8559BV8, EDO, BU2
58330.720.7793BU2

Interfaces

3 interfaces between chains.

  • A–D · 527 Ų buried · 4 hydrogen bonds · protein-protein
  • B–C · 490 Ų buried · 4 hydrogen bonds · protein-protein
  • B–D · 357 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 6EQS · Human Sirt5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29 · the same entry in another collection · chain D against D, TM-score 1.00
  • Q9NXA8 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacylase sirtuin-5… · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.